Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Akebia Threapeutics Inc (AKBA)

168 + Investors. Track Smart Money conviction in AKBA. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +2
Streak
1Q ▲
Buyers last Q
47%

Smart Money Signals — AKBA

Based on 169 hedge funds · latest filing: 2026 Q1 · updated quarterly

📈

Buying streak — 1 quarter in a row

last 6Q
For 1 consecutive quarter, more hedge funds added AKBA than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
🏔️

At the ownership peak (97% of max)

97% of all-time peak
169 hedge funds hold AKBA right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.
📶

Steady growth — +17% more funds vs a year ago

fund count last 6Q
+25 new funds entered over the past year (+17% YoY). Gradual, steady growth in institutional ownership is generally a healthy signal — not a speculative rush, but consistent conviction.
🟠

More sellers than buyers — 47% buying

77 buying87 selling
Last quarter: 87 funds reduced or exited vs 77 that bought or added. When more than half of active funds are selling, it's a caution flag — especially if the stock price hasn't moved down yet.
📈

More new buyers each quarter (+10 vs last Q)

new funds entering per quarter
Funds opening a new AKBA position: 32 → 37 → 24 → 34. A growing influx of new institutional buyers means the asset is still gathering momentum — the consensus hasn't fully saturated yet.
🔒

54% of holders stayed for 2+ years

■ 54% conviction (2yr+) ■ 23% medium ■ 23% new
91 out of 169 hedge funds have held AKBA for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.
💎

Buying through price weakness — shares -14%, value -38%

Value
-37%
Shares
-13%
Last quarter: funds added -14% more shares while total portfolio value only changed -38%. Institutions were buying while the price was falling — a high-conviction accumulation signal. They're deliberately loading up on the dip.
📊

Peak discovery — momentum slowing

31 → 32 → 37 → 24 → 34 new funds/Q
New funds entering each quarter: 32 → 37 → 24 → 34. AKBA is well-known in the hedge fund world, but fresh entries are gradually declining. The explosive phase of institutional discovery is likely behind us.
🏛️

Veteran-anchored — 61% veterans vs 27% newcomers

■ 61% veterans ■ 13% 1-2yr ■ 27% new
Entry-cohort mix of 175 holders: 106 (61%) are 2+ year veterans, 22 entered 1–2 years ago, and 47 (27%) joined within the past year. A veteran-weighted cap table skews toward institutional memory over fresh momentum.
🏆

Elite ownership — 48% AUM from top-100 funds

48% from top-100 AUM funds
42 of 168 holders are among the 100 largest funds by AUM, controlling 48% of total institutional value in AKBA. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.
3.7
out of 10
Low Exit Risk
Exit risk score 3.7/10 — low institutional crowding. Ownership is below peak levels, holder base is relatively sticky, and buying momentum is positive.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — AKBA

In 2026 Q1, 77 hedge funds were net buyers of AKBA (34 opened a new position, 43 added to an existing one), while 87 reduced or exited (55 trimmed, 32 sold completely) — a 47% buyer ratio, indicating roughly balanced activity. 48% of total institutional value in AKBA is held by top-100 AUM funds, reflecting elite-tier ownership quality. Net fund flow last quarter: +2 funds (more new holders than closures). Total institutional holders: 169.

Hedge Fund Ownership: AKBA

How many hedge funds hold AKBA — quarterly history vs. share price
Quarterly hedge fund ownership of AKBA vs. share price

Market Analysis: AKBA

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: AKBA

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy Akebia Threapeutics Inc (AKBA) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much AKBA has moved relative to its sector benchmark (XLV) since the 2026 Q1 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End March 31, 2026 · 77d ago
AKBA
-29.2%
XLV
+4.3%

AKBA outperformed XLV by -33.5% since March 31, 2026.

Since 13F Filing Date May 15, 2026 · 32d ago
AKBA
-7.2%
XLV
+5.4%

Since the filing became public, AKBA outperformed XLV by -12.6% .

Interpretation: The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference. Learn more →

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

18 top-rated funds 0 high-conviction
Consensus
5.6
/ 10
breadth
×
Elite
0.1
/ 10
conviction
Hedge Fund Positioning: AKBA
168 + Investors

Track Smart Money conviction in AKBA. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q1) Prior (2025 Q4) Change
Funds Holding 168 167 0.6%
13F Shares 103M 119M -13.8%
Total Value $140M $225M -37.61%
New Positions 33 24 +9
Increased Positions 41 64 -23
Closed Positions 32 31 +1
Reduced Positions 54 48 +6
Total Calls 4 5 -20.0%
Total Puts 3 2 50.0%
PUT/CALL Ratio 0.75 0.4 Neutral

Statistics: AKBA

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

168 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in AKBA. Verified SEC 13F-HR filings.

QUARTER:
Top 25 AKBA holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Virtus Advisers, LLC 0.20% 308,000 $428K
2 Elevation Advisory Partners LLC 0.17% 120,000 $181K
3 Nantahala Capital Management, LLC 0.10% 2,000,000 $2.8M
4 EntryPoint Capital, LLC 0.08% 201,749 $280K
5 Orchard Capital Management, LLC 0.08% 53,510 $74K
6 Mangrove Partners IM, LLC 0.04% 375,954 $523K
7 Round Rock Advisors LLC 0.04% 166,089 $231K
8 Hennion & Walsh Asset Management, Inc. 0.03% 633,253 $880K
9 Caitong International Asset Management Co., Ltd 0.03% 103,652 $144K
10 Unified Investment Management 0.03% 18,000 $25K
11 PFG Private Wealth Management, LLC 0.02% 37,335 $52K
12 Voleon Capital Management LP 0.02% 675,656 $939K
13 Empirical Asset Management, LLC 0.01% 35,000 $49K
14 Graham Capital Management, L.P. 0.01% 248,352 $345K
15 Wealth Effects LLC 0.01% 16,000 $22K
16 Headlands Technologies LLC 0.01% 48,658 $68K
17 Profund Advisors LLC 0.01% 147,109 $204K
18 Parkwoods Wealth Partners, LLC 0.01% 21,000 $29K
19 Eagle Wealth Strategies LLC 0.01% 10,000 $14K
20 XTX Topco Ltd 0.01% 244,453 $340K
21 Carr Financial Group Corp 0.01% 15,581 $22K
22 Eaton Financial Holdings Company, LLC 0.01% 11,800 $16K
23 Independent Wealth Network Inc. 0.01% 13,003 $18K
24 PDS Planning, Inc 0.00% 50,000 $70K
25 Sapient Capital LLC 0.00% 200,000 $278K
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Akebia Threapeutics Inc (AKBA)

What does the Smart Money Trend signal show for AKBA?

Buying streak — 1 quarter in a row: For 1 consecutive quarter, more hedge funds added AKBA than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for AKBA?

More sellers than buyers — 47% buying: Last quarter: 87 funds reduced or exited vs 77 that bought or added. When more than half of active funds are selling, it's a caution flag — especially if the stock price hasn't moved down yet.

What is the fund quality score for AKBA holders?

Elite ownership — 48% AUM from top-100 funds: 42 of 168 holders are among the 100 largest funds by AUM, controlling 48% of total institutional value in AKBA. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.

How long have hedge funds held AKBA?

54% of holders stayed for 2+ years: 91 out of 169 hedge funds have held AKBA for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Is it too late to buy Akebia Threapeutics Inc (AKBA) following the 2026 Q1 hedge fund 13F filings?

As of today, AKBA has moved -7.2% since the 2026 Q1 13F filing date (May 15, 2026), compared to +5.4% for the XLV sector ETF — an outperformance of -12.6%. Since the quarter end (March 31, 2026), AKBA has gained -29.2% vs +4.3% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →